Tzield Approval Expands to Younger Patients - Top_Thought_Leaders - MDSpire

Tzield Approval Expands to Younger Patients

First disease-modifying option available for children as young as 1 year with stage 2 type 1 diabetes

  • By

  • Kathryn Wighton

  • April 22, 2026

  • 2 min

Share

Top Thought Leaders in Urology

Brief introduction explaining scope and methodology.

Original Source(s)

Tzield Approval Expands to Younger Patients

  • by Kathryn Wighton

  • April 22, 2026

Related Content

Alarms in Long-Term Home Mechanical Ventilation

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Using the NASSS–Complexity Assessment Tool to Evaluate the Implementation of “Cadê O Kauê?”: Chat-Story Intervention for Youth Participation in Mental Health Promotion in Brazil